tiprankstipranks
Datametrex AI Limited (TSE:DM)
:DM

Datametrex AI (DM) AI Stock Analysis

88 Followers

Top Page

TSE:DM

Datametrex AI

(DM)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
C$0.07
▼(-18.89% Downside)
Action:ReiteratedDate:04/11/26
The score is primarily constrained by weak financial performance—heavy losses and ongoing negative operating/free cash flow—despite modest revenue growth and improved leverage. Technicals are mixed, with short-term improvement but a broader downtrend and bearish MACD. Valuation support is limited because the negative P/E reflects unprofitable operations and no dividend yield is available.
Positive Factors
Industry & business focus
The company operates in applied AI and data-driven software, sectors with durable secular demand for analytics and automation. Over 2–6 months this structural market growth supports sustained need for DM’s services, enabling longer-term revenue opportunities if execution follows.
Negative Factors
Negative gross profit & margins
A negative gross profit and extremely negative net margin indicate the core business is not covering direct costs. This structural profitability gap risks ongoing cash burn, requires material margin improvement to reach break-even, and undermines long-term scalability.
Read all positive and negative factors
Positive Factors
Negative Factors
Industry & business focus
The company operates in applied AI and data-driven software, sectors with durable secular demand for analytics and automation. Over 2–6 months this structural market growth supports sustained need for DM’s services, enabling longer-term revenue opportunities if execution follows.
Read all positive factors

Datametrex AI (DM) vs. iShares MSCI Canada ETF (EWC)

Datametrex AI Business Overview & Revenue Model

Company Description
Datametrex AI Limited, together with its subsidiaries, provides collecting, analyzing, and presenting structured and unstructured data using its patented machine learning and artificial intelligence in Canada and South Korea. The company operates ...
How the Company Makes Money
null...

Datametrex AI Financial Statement Overview

Summary
Despite 7.7% TTM revenue growth, profitability is severely weak (gross profit turned negative; net margin ~-115%) and both operating and free cash flow remain negative, indicating ongoing cash burn. Leverage has improved to moderate levels (debt-to-equity ~0.54), but deeply negative returns and continued losses remain the dominant risk.
Income Statement
24
Negative
Balance Sheet
46
Neutral
Cash Flow
28
Negative
BreakdownDec 2025Jun 2025Mar 2024Dec 2022Mar 2022
Income Statement
Total Revenue5.19M6.49M7.80M30.49M49.03M
Gross Profit-695.90K3.07M2.17M10.20M21.03M
EBITDA-4.48M-1.24M-6.95M-13.46M13.29M
Net Income-5.95M-3.06M-19.14M-17.26M9.09M
Balance Sheet
Total Assets14.59M4.99M12.71M36.00M42.64M
Cash, Cash Equivalents and Short-Term Investments1.88M427.11K1.13M9.41M17.99M
Total Debt4.93M1.84M5.19M4.53M253.77K
Total Liabilities5.55M4.33M11.70M13.23M10.15M
Stockholders Equity9.05M656.40K1.00M22.77M32.49M
Cash Flow
Free Cash Flow-2.83M-1.57M-6.94M-2.28M11.42M
Operating Cash Flow-2.83M-1.22M-5.62M-249.09K11.45M
Investing Cash Flow32.51K59.10K-969.15K-3.79M-234.41K
Financing Cash Flow4.18M1.21M-254.18K-2.40M2.19M

Datametrex AI Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.09
Negative
100DMA
0.09
Negative
200DMA
Market Momentum
MACD
>-0.01
Positive
RSI
39.78
Neutral
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DM, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.78 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:DM.

Datametrex AI Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
C$45.80M0.4645.36%37.95%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
51
Neutral
C$104.58M-0.19-0.43%-59.23%-100.34%
51
Neutral
C$135.90M60.68-13.00%3.40%-691.81%
44
Neutral
C$9.16M-1.20-212.14%-56.02%91.71%
39
Underperform
C$3.87M-15.43-3428.85%-15.33%47.13%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:DM
Datametrex AI
0.06
-0.02
-20.00%
TSE:KNR
Kontrol Technologies
2.50
0.00
0.00%
TSE:VIS
Visionstate
0.02
>-0.01
-25.00%
TSE:ALYA
Alithya Group
1.44
-0.18
-11.11%
TSE:SPOT
GoldSpot Discoveries
0.33
0.17
100.00%

Datametrex AI Corporate Events

Business Operations and StrategyFinancial Disclosures
Datametrex Wins $6 Million AI Data Centre Deal With Fortune 500 Client
Positive
Apr 9, 2026
Datametrex AI Limited has secured approximately $6 million in purchase orders from an international Fortune 500 conglomerate to support data centre expansion and optimization. The five-year contracts, which include software licensing and technical...
Business Operations and Strategy
Datametrex’s Paymetrex Taps Hilco Global to Unlock Value from SoftPOS Patent Portfolio
Positive
Apr 8, 2026
Datametrex AI&#8217;s subsidiary Paymetrex Payment Solutions has entered a strategic agreement with Hilco Global&#8217;s IP Services practice to help monetize Paymetrex&#8217;s patent portfolio, particularly in the fast-growing SoftPOS and mobile ...
Business Operations and Strategy
Datametrex Subsidiary Licenses SoftPOS Patent Portfolio to AnywhereCommerce
Positive
Mar 19, 2026
Datametrex AI&#8217;s subsidiary Paymetrex has entered a royalty-bearing patent license agreement with payments firm AnywhereCommerce, covering Paymetrex&#8217;s U.S. and Canadian patents for secure transaction processing and mobile-based payment ...
Business Operations and StrategyProduct-Related Announcements
Datametrex Integrates AI Into EMR Platform to Ease Physician Workload
Positive
Mar 10, 2026
Datametrex AI has integrated new AI software into its electronic medical records system to assist physicians at the point of care, adding capabilities such as automated clinical documentation, intelligent document classification, real-time chartin...
Business Operations and Strategy
Datametrex’s Paymetrex Taps Pelent AI to Turbocharge Patent Licensing Push
Positive
Feb 23, 2026
Datametrex&#8217;s subsidiary Paymetrex has engaged Pelent Patent Analytics to embed Pelent&#8217;s specialized AI into its patent licensing workflow, aiming to better identify high-value licensing targets and unlock greater value from its IP port...
Business Operations and StrategyFinancial Disclosures
Datametrex Wins $1 Million Hyperconverged Infrastructure Order from Asian Fortune 500 Client
Positive
Feb 18, 2026
Datametrex AI Limited has secured a purchase order worth about $1 million from a large South Korea-based Fortune 500 conglomerate with diversified interests, primarily for Nutanix-based hyperconverged infrastructure software licenses. The deal, wh...
Business Operations and StrategyFinancial Disclosures
Datametrex Wins $500,000 Data Centre Order From South Korean Fortune 500 Client
Positive
Feb 13, 2026
Datametrex AI Limited has secured an approximately $500,000 purchase order from a South Korea-based Fortune 500 client for data centre operations and infrastructure solutions, carrying an estimated profit margin of about 20%. The mandate centers o...
Business Operations and Strategy
Datametrex’s Paymetrex Launches Patent Licensing Drive With First U.S. Deal
Positive
Feb 9, 2026
Datametrex&#8217;s subsidiary Paymetrex has launched a patent licensing program to monetize its portfolio of secure transaction processing and payment workflow technologies, signing its first non-exclusive U.S. licensing deal that will generate an...
Business Operations and StrategyFinancial Disclosures
Datametrex’s Paymetrex Lands First U.S. Patent Licensing Deal in Payments
Positive
Feb 9, 2026
Datametrex&#8217;s subsidiary Paymetrex has launched a patent licensing program to monetize its extensive payments and transaction-processing intellectual property, signing a first non-exclusive deal with a major U.S. payment solutions provider. T...
Business Operations and StrategyProduct-Related Announcements
Datametrex Deepens Push Into Hyperconverged Data Centre Infrastructure
Positive
Feb 4, 2026
Datametrex AI Limited is expanding its presence in modern data centre operations by deploying Nutanix-based hyperconverged infrastructure solutions that integrate servers, storage and networking into a single platform, following successful impleme...
Business Operations and Strategy
Datametrex Subsidiary Paymetrex Unveils Patent Licensing Drive in Mobile Payments
Positive
Feb 2, 2026
Datametrex AI&#8217;s subsidiary Paymetrex Payment Solutions has launched a patent licensing program to monetize its portfolio of U.S. and Canadian patents covering mobile and electronic payment technologies, some of which have been in place since...
Business Operations and Strategy
Datametrex AI to Court Investors at AlphaNorth Capital Event
Positive
Jan 15, 2026
Datametrex AI Limited will participate in the AlphaNorth Capital Event hosted by CEM from January 16&#8211;18, 2026, an investor-focused forum that connects growth-stage companies in resource, technology, biotech and special situations with capita...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 11, 2026